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ABSTRACT OF THESIS

INVESTIGATING THE EFFECTS OF IN-VIVO THERAPEUTIC HYPOXIA TREATMENT
PARADIGMS IN NEURITE OUTGROWTH PATTERNS

Spinal cord injury, specifically in the cervical C3-C4 region of the cervical spine,
contributes to impaired breathing and a diminished quality of life. Therefore it is important to find
effective and safe therapeutics to restore breathing function. Indeed, there are a myriad of
research being performed in addition to valuable collaboration amongst different institutions. As
such, inspired by a previous experiment, we decided to test our hypothesis that an enriching
environment consisting of different hypoxic environments - sustained and intermittent hypoxia
alongside normoxia - would result in neurite outgrowth. Moreover, we hypothesized that
sustained hypoxia would result in the greatest neurite outgrowth, followed by intermittent
hypoxia. Lastly, we predicted that normoxia would result in the smallest amount of neurite
outgrowth. We tested this hypothesis first in-vivo by placing female, retired breeder rats (n=3) in
sustained or intermittent hypoxia or normoxia conditions for a period of 2 hours and 32 minutes.
This was followed by dorsal root ganglion (DRG) culturing, plating, and fixing. Notably, because
the premise of this experiment is a hybrid of both an in-vivo and in-vitro (specifically an ex-plant)
we cannot, with accuracy, state that the growths are of axonal in nature. As such, we will refer
them to as neurite. We used NeuronJ to manually trace and measure neurite outgrowth. In
addition, we also utilized the Sholl analysis to better understand neurite arborization and their
location in relation to the soma. We conclude that, interestingly, normoxia resulted in the greatest
neurite outgrowth, followed by intermittent hypoxia and lastly by sustained hypoxia. As such, this
experiment augments others experiments that show the promising therapeutic effects of
intermittent hypoxia in restoring breathing function whether it is through enhancement of the
crossed phrenic pathway or increased serotonergic receptor activation.
KEYWORDS: hypoxia, neurite, outgrowth, sprouting, respiratory function
Jae Hyun Yoo
April 21, 2022

INVESTIGATING THE EFFECTS OF IN-VIVO THERAPEUTIC HYPOXIA TREATMENT
PARADIGMS IN NEURITE OUTGROWTH PATTERNS

By
Jae Hyun Yoo

Dr. Warren J Alilain
Director of Thesis
Dr. John Gensel
Co-chair/Director of Thesis
Dr. Melinda Wilson
Director of Graduate Studies
April 21, 2022

ACKNOWLEDGEMENTS

This thesis, while an individual work, benefited from the insight and direction of several
people. I would like to thank Dr. Warren Alilain, PhD for taking a chance on me and allowing me
to join his laboratory. Without his mentorship and guidance, I would not have been able to
complete this experiment experiment that has the potential to contribute to more groundbreaking
research as it relates to spinal cord injuries and neurological disorders. In addition, I would like to
thank Aaron Silverstein, BS, BS who, alongside, Dr. Alilain, provided unwavering support in my
overarching goals, and this project. I would like to also thank Sydney Speed, Chris Calulot, BS,
Caroline Devine, and Michael Sunshine, PhD for all their assistance and patience in teaching me
all the steps required to conduct this experiment in a timely and accurate manner. Lastly, I would
like to thank the entire Alilain laboratory for welcoming me into the lab with open arms and
helping me whenever I needed it; without you all this project would not have come to fruition.

iii

TABLE OF CONTENTS

Acknowledgements……………………………………………………………………………….iii

List of Tables………………………………………………………………………………………v

List of Figures……………………………………………………………………………………vi

Chapter 1: Introduction……………………………………………………………………………1

Chapter 2: Methods………………………………………………………………………………..7

Chapter 3: Results………………………………………………………………………………..15

Chapter 4: Discussion…………………………………………………………………………….23

Chapter 5: Conclusion…………………………………………………………………………….31

References………………………………………………………………………………………..32

Vita……………………………………………………………………………………………….34

iv

LIST OF TABLES

Table 1, Total Neurite Outgrowth, Sustained Hypoxia………………………………16

Table 2, Total Neurite Outgrowth, Intermittent Hypoxia……………..17

Table 3, Total Neurite Outgrowth, Normoxia……………..18

Table 4, One way ANOVA Statistical Analysis…..19

v

LIST OF FIGURES

Figure 1, Respiratory Neural Circuitry…………………………………………………………….6

Figure 2, Dorsal Root Ganglion……………………………………………………………………6

Figure 3, Schematic Image of Well Plates………………………………………………………..13

Figure 4, Concentric Circles Used To Measure Dendritic Arborization………………………….14

Figure 5, Graph Depicting Sholl Analysis………………………………………………………..14

Figure 6A, Manual Quantification of Average Dorsal Root Ganglion Outgrowth……………….20

Figure 6B, Automated Quantification of Average Dorsal Root Ganglion Outgrowth……………20

Figure 6C, Fluorescent Microscopy Image of Single Dorsal Root Ganglion ……………………21

Figure 6D, Sholl Analysis of Dorsal Root Ganglion Outgrowth…………………………………21

Figure 6E, Independent, Blinded Quantification Results……………………………………..…22

Figure 7, HIF-1a Expression Across Different Treatment Paradigms……………………………28

Figure 8, Image of Dorsal Root Ganglion Leaving And Projecting Back Into Soma……………28

vi

Figure 9A, Manual Quantification of Dorsal Root Ganglion Neurite Outgrowth (CED)……….29

Figure 9B, Independent, Blinded Quantification Results (CED)………………………………..29

Figure 9C, Unpaired T-Test Statistical Analysis (CED)…………………………………………30

Figure 9D, Sholl Analysis of Dorsal Root Ganglion Outgrowth (CED)…………………………30

vi

CHAPTER 1: INTRODUCTION
The history of spinal cord injuries (SCI) can be traced back as far as ancient Egypt during
a time in which physicians believed the injury to be irreversible and untreatable.1 Indeed, it is
reasonable to say that since that time, there have been many advances in medicine and technology
allowing for a degree of restoration of function following injury. Yet, with the majority of spinal
cord injuries occurring at the cervical level, this can lead to severe impairment of the respiratory
system including diaphragm paresis and paralysis.2 Moreover, it has been shown that the more
rostral the level of injury, the more likely it is that the injury will affect breathing function.
Indeed, following a traumatic SCI, respiratory dysfunction is the primary cause of death.3 As of
now, there are no cures to alleviate diaphragmatic paralysis and as such, without proper
ventilation, patients with cervical SCI must rely on mechanical ventilations.3 Moreover, while
effective, mechanical ventilation is not without faults. Mechanical ventilation increases the risk of
infection, pneumonia and death in patients already suffering from SCI.3 As such, despite the level
of SCI (i.e thoracic, lumbar), the main cause of death is a result of respiratory insufficiency.3
The circuitry that describes the neural pathway that innervates the diaphragm has been
extensively studied and well defined. Figure 1 shows a pictorial description of said pathway. The
central nervous system (CNS) is defined as the brain and spinal cord. Importantly, other features
of the CNS that are involved in the breathing circuitry includes the brainstem, of which includes
the midbrain, pons, and medulla. The respiratory neural circuitry begins at the brainstem with
respiratory rhythm generating neurons located inside the pre-Bötzinger complex (PBC) and the
para-facial respiratory group (pFGR) located in the ventral lateral medulla. These neurons
connect to the propriobulbar neurons as well as to the premotor neurons found in the ventral
respiratory group (VRG) found laterally and ventrally to the nucleus ambiguous. The rostral
aspect of the VRG, abbreviated rVRG, contains inspiratory bulbospinal neurons. Neurons project
out of both the rVRG and innervate the ipsilateral and contralateral phrenic motor nucleus.
Moreover, neurons in the phrenic nucleus innervate downward towards the ipsilateral aspect of
the hemidiaphragm (i.e left phrenic nerve innervates the left hemidiaphragm.3
Clinically, cervical SCI, especially the upper region of the cervical spine leads to
impaired neural signaling originating from the brainstem down to the diaphragm; this is the
fundamental cause of diaphragmatic paresis, and ultimately impaired respiratory function. In
order to further study cervical injury in animal models, scientists performed C2 hemisections
(C2Hx) to mimic the human condition. Moreover, a C2Hx, a small incision made to severe one
side of the C2 spinal cord, mimics a SCI and disrupts breathing patterns on the ipsilateral aspect
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of the diaphragm. As such, this incision interrupts the innervation originating from rVRG to the
phrenic motor nucleus. This injury model results in reduced tidal volume (amount of air that
moves in/out of the lungs in a respiratory cycle) and increases breathing frequency. Previous
extensive studies performed on rat models have led to the discovery of an important phenomena
referred to as the cross phrenic pathway. As described earlier, the neurons from the rVRG
innervates the ipsilateral phrenic motor nucleus. Indeed, animal studies have shown that there are
neurons that arise from the rVRG that decussate and thus innervate the contralateral phrenic
motor nucleus. This gave some insight into possible therapeutic avenues that could be taken to
rescue respiratory pattern following SCI at the cervical level.3
This activation of the crossed phrenic pathway (CPP) has been historically induced by
asphyxia, specifically hypoxia or hypercapnia. As such, experiments have sought to target
methods in which to enhance the CPP. For example researchers investigating the effects of
theophylline, a respiratory stimulant, has shown that it enhanced CPP by modulating adenosine
A1 receptors. Specifically, they discovered that respiratory function improved through activation
of the CPP by using an adenosine A1 antagonist and adenosine A2 agonist, simultaneously.
Indeed, while the mechanism is not yet understood, theophylline induced respiratory recovery
lasted for at least 1 month following treatment. In addition, further studies have pointed to the
idea that there may be sex differences as it relates to CPP activation. Moreover, it has been shown
that female rats underwent CPP activation when compared to male rats. There is also the
possibility that the CPP synaptic terminal may be ineffective in innervating the phrenic motor
neurons which would not be able to provide the depolarization necessary in order to drive a
respiratory response. As it has been shown that the phrenic motor neurons decrease in size
following a SCI and are effectively more excitable (i.e Henneman’s principle), more CPP
innervation and activation could allow for more contraction of the diaphragm and increase
respiration.3
Aside from the activation of the crossed phrenic pathway, there have been other
experimental avenues that researchers investigated in order to elicit an increase in respiratory
function following SCI. One of routes taken was to investigate the effects of acute intermittent
hypoxia (AIH) on improving respiratory drive. AIH is characterized by short bouts of hypoxia (i.e
5 minutes) followed by bouts of normoxia (i.e 5 minutes). As such, this paradigm led to phrenic
long term facilitation (pLTP), a type of neural plasticity. Overall, pLTP has been shown the
strengthen synaptic networks that lead to the phrenic motor neurons. Importantly, further studies
have elucidated that pLTP involves serotonergic activation alongside brain derived neurotrophic
factors (BDNF). Similar to the mechanism underlying long term potentiation (LTP) as it relates to

2

learning and memory, serotonin permitted strengthening of glutamatergic synapses - a process
required for pLTF. Indeed, blocking NMDA receptors have been proven to limit pLTF.
Specifically, experimental models have elucidated that the strengthening of the glutamatergic
synapses between the descending respiratory neurons and the phrenic motor neurons is serotoninBDNF dependent as well as activation of 5HT2A receptors. As such, it is likely that serotonin
dependent-BDNF synthesis leads to the strengthening and remodeling of presynaptic and
postsynaptic terminals.3 As we alluded before, the latent crossed phrenic pathway has been
extensively studied as a manner in which we can elicit recovery in respiratory drive following
SCI. Moreover, published studies revealed that serotonin (5HT) indeed plays a significant role in
the activation of the CPP.
Collectively, the mechanisms described above illustrate the ability to exploit endogenous
mechanisms in order to induce plasticity in order to improve respiratory motor output and thereby
lead to recovered breathing patterns among individuals suffering from SCI. As such, the highlight
of our research explored the possible therapeutic effects of acute intermittent hypoxia, sustained
hypoxia and normoxia and how it relates to axonal regeneration in the peripheral nervous system
(PNS), specifically dorsal root ganglion (DRG). Previous studies (Fuller et al., 2000; Mitchell et
al., 2001; Baker-Herman et al., 2002) have demonstrated that intermittent hypoxia under the
following paradigm - 3 5 minutes intervals of a hypoxic challenge - was able to induce phrenic
motor output in a serotonin dependent manner. Indeed, a study conducted by Mitchell et al (2003)
demonstrated that chronic and acute intermittent hypoxia treatments following chronic SCI
(C2Hx) led to spontaneous recovery on the ipsilateral side of injury, evident by EMG recordings
that show an increase in amplitude of inspiratory burst as well as a serotonin-dependent plasticity.
It is important to note here that these results highlights improved respiratory motor output in
chronic, not acute SCI as research shows that intermittent hypoxia is not effective until 4-8 weeks
post injury.4 As such more research needs to be performed in order to find therapeutics to treat
patients with acute SCI. Another important limitation of this therapeutic tool centers around the
duration of intermittent hypoxia, either acute or chronic, and how it relates to the development of
pathophysiology. Simply put, the applications of CIH or AIH can be offset as it has been
implicated in the development of side effects such as neurocognitive deficits (likely due to
decreased oxygen), hippocampal cell death, and impaired sympathetic chemoreceptor function.4,5
It is important to also highlight the duration of pLTF following bouts of chronic and acute
intermittent hypoxia. Moreover, Fuller et al (2005) points out that while the duration pLTF in
acute intermittent hypoxia is unknown, pLTF elicited by chronic intermittent hypoxia (defined as
12h per night for 7 nights) lasted for up to 24hrs (normally 90 minutes). In addition, chronic
intermittent hypoxia enhanced CPP for up to 2 weeks following a C2Hx, with an increase in
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respiratory motor output for up to 1 week. Together, with the deleterious effects of prolonged
exposure to a hypoxic exposure and the unknown during of pLTF in acute intermittent hypoxia, it
may be useful to pursue another therapeutic route involving physical therapy to further augment
respiratory motor output in order to strengthening respiratory muscles.4
Prior research has shown that it is the failure of CNS cells to regenerate that leads to
permeant disabilities in patients who suffer from SCI. In this sense, there is a stark contrast
between peripheral nervous system (PNS) cells in that these cells have been shown to take part in
a regenerative paradigm and as such, it is important to understand the mechanism PNS cells
utilize in order to regenerate. While it is not difficult to maintain the integrity of CNS tissue once
they have been harvested, the main issue lies in the manner which they are harvested. Moreover,
DRGs (figure 2) are pseudounipolar and such, in addition to their peripheral branches, they are
also able to extend axons into the spinal cord and/or brainstem. As such, many researchers utilize
dorsal root ganglions, sensory neurons that in some way, bridges the gap between the peripheral
and central nervous systems.5
Interestingly, it has been shown that injury to the peripheral axon leads to neurite
outgrowth and thus activation of pro-regenerative gene expression as compared to injury to the
central axon branch. Moreover, multiple regeneration associated genes (RAGs) have been
identified as it relates to promoting neurite regeneration and outgrowth. Yet, it has been
elucidated that it is not just RAG that promotes the regenerative capacity in dorsal root ganglia
but the activation of some, in addition to inactivation of other RAGs. Of particular interest to our
research was hypoxia inducible factor 1 alpha (HIF1a) and its downstream target gene vascular
endothelial growth factor A (VEGF-A). Under normal conditions (i.e normal oxygen levels or
normoxia), HIF1a is hydroxylated and this makes it a target for ubiquitination and subsequent
degradation via proteasome. However, during hypoxic conditions (i.e low oxygen levels), the rate
of HIF1a hydroxylation is reduced, leading to the accumulation and translocation of HIF1a to the
nucleus where it will bind to hypoxia response elements. Prior work by Nix et al (2014) has
shown that deletion of HIF1a leads to reduced regeneration but this work had not been done on
mammals. As such, Cho et al (2015) demonstrated that acute intermittent hypoxia was able to
stimulate axonal regeneration in vivo in mice. Moreover, AIH (10 minutes at 8% oxygen
interspersed with normoxia) led to the upregulation of HIF1a but also downstream target genes
such as VEGFA.6
Previous research sought to investigate HIF1a and VEFGa expression levels at the end of
each treatment paradigm, which included sustained hypoxia, intermittent hypoxia and normoxia.2
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As alluded to before, it is important to ensure that the level of hypoxia induced does not lead to
pathological conditions (i.e neurocognitive disorders). As such, previous studies such as the one
described wanted to elucidate the proper level of hypoxia that will lead to the ideal level of
HIF1a/VEGFa expression as it relates to regeneration and neurite outgrowth. In order to measure
neurite outgrowth, we decided to utilize DRGs as they are easy to harvest and culture and have
regenerative capabilities. As such, previous studies conducted by Caroline Devine (Alilain Lab)
were inspired by Cho et al (2015) by treating DRGs with sustained hypoxia and normoxia in
vitro. Further, in order to further augment research highlighted here, my experimental design
focused on providing an enriching environment as it relates to sustained and intermittent hypoxia
and normoxia in vivo and determine how these treatments translate in vitro when dorsal root
ganglia were cultured on a dish. As with Caroline Devine’s study, I utilized DRGs as a way to
measure total neurite outgrowth but to see how DRGs how pronounced the treatment paradigms
can persist, from an in vivo treatment to in vitro culturing. We hypothesize that intermittent
hypoxia followed by sustained hypoxia and lastly normoxia (SH > IH > N) would promote the
greatest amount of axonal outgrowth.
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Figure 1. Neural circuitry

Figure 2: Dorsal root ganglion depicting central and peripheral branches
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CHAPTER 2: METHODS
Please note that all animal care/handling were performed under strict compliance with the
Institutional Animal Care and Use Committee regulations here at the University of Kentucky
Part 1 of dorsal root ganglion (DRG) harvest: dissection of DRG from rat spinal cords
For this series of experiments, we utilized 3 uninjured, retired breeder female Sprague
Dawley rats (Envigo-Harlan, Indianapolis, IN, USA). Each rat was assigned a specific treatment
paradigm (i.e intermittent hypoxia, sustained hypoxia, and normoxia) and were subject to said
treatment for a duration of 5 consecutive days. For intermittent hypoxia, the rat was treated with
10% oxygen interspersed with normal oxygen concentration or normoxia (20% oxygen) for a
period of 2 hours and 32 minutes. For sustained hypoxia, the rat was treated with a constant flow
of 10% oxygen for 2 hours and 32 minutes. The hypoxia treatments were performed using the
OxyCycler model A84XOV Atmosphere-controlled Chamber (Biospherix, Ltd., New York,
USA). Normoxia treatment was subject to a rat at 20% oxygen for 2 hours and 32 minutes as a
means of control. In order to maintain a narrow window between treatment and ex-plant cultures
immediately following treatment, we anesthetized the rats using carbon dioxide under a hood at a
rate of 5L/min. After the rats were anesthetized, in a faraday cage, we utilized curved forceps and
scissors to cut the skin rostrocaudally (top down) along the midline of the spine. This allowed for
the exposure of musculature which was cut through using scissors in order to expose the spinal
column. Using heavy dissecting scissors, we cut the rat spinal column at the base of the skull and
at the lumbo-sacral level of the spinal cord. Once removed, we carefully cut away the
musculature and surrounding ribs as to further expose the spinal column. Importantly, while
dissecting away muscle and ribs, it is important to identify the spinous processes. After dissecting
away muscle, using the spinal process as a guide, we cut down the midline of the spinal cord and
separated the column into the left and right sides.
We pinned one half of the exposed spinal cord onto a rubberized matt (blue) which was
laid onto an ice pack to maintain the tissue. In addition, we prepared 3, 1mL microcentrifuge
containing 1X calcium-magnesium free Hank’s balanced salt solution (CMF-HBSS) which was
placed in a bucket of ice; this is the solution we placed the DRGs after extracting them from the
cord. To save time, before dissections started we placed 3 aliquot containing 1.5mL of
collagenase/dispase in a 37ºC water bath in the cell culture room to allow ample time to thaw;
each collection of DRGs from different treatments were placed in their own aliquot. For
reference, the aliquots of collagenase/dispase are in neurobasal A media and are placed in the
-20ºC freezer. Using a dissection microscope, microscissors, and two small forceps we dissected
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out the DRGs from each side of the dissected spinal column. It is important to note here that
when the DRGs were removed, their axonal processes were cut, leaving only the soma. The
DRGs were placed in the 1mL microcentrifuge tube with CMF-HBSS. It is important to note here
that we labelled the microcentrifuge tubes with the respective treatment paradigms each DRG
underwent in-vivo. The steps listed above were performed on all rats following their respective
treatment paradigms.
Upon dissection of the final DRGs from the final rat, in the cell culture room, we
removed the 1mL of CMF-HBSS from each microcentrifuge tube and added 1.5mL of
collagenase/dispase. Collagenase/dispase is an enzymatic mixture that allows us to digest DRGs
prior to culturing. Specifically, collagenase degrades collagen while dispase degrades proteases in
a nonspecific manner. We decided to wait until all the DRGs were harvested from all rats before
proceeding with this step in order to ensure consistency and to make sure all DRGs were placed
in the aliquot of collagenase/dispase at the same time. We added parafilm to the tops of the
microcentrifuge tube to prevent evaporation of the solution as well as to prevent spillage. We
gently shook the microcentrifuge tubes in order to mix the DRGs with the enzyme. Following, we
placed each microcentrifuge tube into a 50 mL conical tube filled with tissue paper. The purpose
of the tissue paper was to allow for the microcentrifuge tube to fit inside the conical tube.
Because we had 3 microcentrifuge tubes with DRGs, we used 3 conical tubes. The conical tubes
containing the microcentrifuge tubes were then placed on top of a rocker/shaker; the rocker was
set at 40 rotations per minute (RPM). This allowed the conical tubes to gently shake the DRGs
overnight, for approximately 16 hours.
Part 2 of dorsal root ganglion (DRG) harvest: plating neurons onto well plates
We prepared the six well plates by adding coverslips to the bottom of each well.
After approximately 16 hours on the rocker/shaker, remove the 50mL conical tubes from
the rocker and allow the cells to settle to the bottom of the microcentrifuge tube. Recall the
following steps were performed for three separated microcentrifuge tubes. In the tissue culture
hood within the cell culture room, we removed the collagenase/dispase from each
microcentrifuge tube into a waste beaker and added 1 mL of chilled 1X CMF-HBSS. Following,
we centrifuged them at 2000 RPM for 2 minutes. This wash and centrifuge step was performed 3
times, with specific differences at each step here described. Following the first centrifuge, we
used a P1000 micropipet to triturate the cells at the bottom in order to break them up; on average
we triturated 10x. Following the second and third triturations, we used fire-polished glass pipet
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until the DRGs broke apart and the solution looked homogenous and free of large clumps.
Following the third wash, we added 500mL of neurobasal A (NBA; 75.75mL of neurobasal media
A, 1.5mL of B27, 750µl of pen/strep, 187.5µl of glutaMAX) complete media.
We used a 1:5 dilution (vs a 1:3 dilation stated in the protocol) in order to enhance our
ability to visualize the cells under the microscope. As such, for each condition we used 10µl of
cell solution, 10µl of trypan blue (stains dead neuronal cell bodies), and 30µl of NBA and added
it to a .5mL microcentrifuge tube. We added 10µl of the cell/trypan blue/NBA mix into the groove
of a hemacytometer and placed the coverslip. It is important to have wiped off the coverslip with
a kimwipe to ensure that there are no dust particles. We used a microscope to visualize neurons under a microscope, neurons are circular cells and have a halo surrounding them. The
hemacytometer is divided into grids (4) and we counted the number of neurons per grid. On
average there should be between 6-9 cells per grid. Following, we determined that we had enough
cells in solution to culture 5,000 cells per well. After determining the average number of cells per
treatment, we calculated the total volume needed to culture two plates (6 wells each plate for a
total of 12 wells; some treatments did not have 12 wells). Following, we calculated the volume of
cell suspension we needed to add to the total volume, of which we added 1.5mL into each well.
We then placed all the cell culture plates (six total) into the incubator at 37ºC for 24 hours.
We decided to plate each condition on two plates as to see the difference in neurite
outgrowth following a one day incubation in NBA media vs a seven day incubation/media
exchange with anti-mitotic.
Part 3A dorsal root ganglion (DRG) harvest: cell fixation and media collection
We labeled each 6 well plate from numbers 1-12. As such, we used the well plates labeled
7-12 to serve as the one day incubation cohort. We removed these plates from the incubator and
removed 1mL of the media into a new 50mL conical tube. We labeled each conical tube with the
corresponding treatment paradigm (IH, SH, normoxia) and put it in the -80ºC freezer for
preservation. Following this, we fixed the neurons with 4% paraformaldehyde (PFA). Important
to note here at all cell fixation steps took place in a special chemical hood. We prepared the 4%
PFA by first adding 10mL of 10X PBS to a 50mL conical tube; ensure that the 10X PBS is at
room temperature or the cells will burst. Then we added the 10mL pre-made ampoule of 8% PFA.
Using a 10mL syringe and 18 gauge feeding needle, we removed the PFA and added it to the PBS
mix. Because we had already removed media and had 0.5mL of media left, we removed the
remaining media and added 1mL of 4% PFA to each well. We let this incubate at room
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temperature of 30 minutes. After the 30 minutes, we removed the PFA into a PFA only waste
beaker and washed each well with PBS three times. After the last wash, we added 1mL of PBS,
wrapped the plates in parafilm and placed into the 4ºC refrigerator.
Part 3B of dorsal root ganglion (DRG) harvest: media exchange
Following the 24 hour incubation period at 37ºC, we performed a media exchange on the
other 3 well plates. The new media contains anti-mitotic agents as a means to prevent the growth
of other cell types. As such, this will make it easier for us to quantify neural outgrowth following
seven days of incubation at 37ºC. We calculated the total volume of solution needed for all well
plates (calculation for normoxia is different as only 5 wells were plated). We then calculated the
necessary amount of Fudr and Ara-C. Each well had 1.5mL of NBA media prior to incubation. As
such, we removed 1mL of the old media and kept 0.5mL in each well to prevent the cells from
drying out. Following, we added 1mL of the anti-mitotic mix to each well. The well plates were
then placed back into the 37ºC incubator.
Part 4 of dorsal root ganglion (DRG) harvest: Primary antibody
After incubating the well plates immersed in anti-mitotic media for seven days, we fixed
the cells using 4% PFA. Please refer to the steps listed above for the cell fixation process.
Following the cell fixation, we put the well plates into the refrigerator overnight. At the start of
the staining process, we removed all wells from the refrigerator and allowed the cells to warm in
room temperature. Then we calculated the total volume of blocking solution needed for all 6 well
plates and subsequently calculated the amount of normal goat serum (NSG), BSA, and Triton
X-100. We gently vacuum aspirated the PBS and added 750µl of the blocking solution to each
well. We allowed this to sit at room temperature for 30 minutes. Save the remaining amount of
blocking solution to be used in day five or secondary antibody staining.
During the incubation period, we prepared the primary antibody (1:1000 dilution) of
mouse anti-rat ßIII tubulin (Sigma T8578). After the 30 minute incubation with blocking solution,
we added 250µl of the primary antibody solution into each well. Each well plate was wrapped in
parafilm and placed in the refrigerator for overnight incubation.
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Part 5 of dorsal root ganglion (DRG) harvest: Secondary antibody - performed in the dark*

This was performed in the dark*:
After overnight incubation, we prepared the secondary antibody, goat anti-mouse IgG
Alexa 594 (Invitrogen A11032) at a dilution of 1:1500; we added the appropriate amount of
secondary antibody into the saved blocking solution from day four.*
We removed the wells from the refrigerator and allowed the cells to warm to room
temperature. We then vacuum aspirated the primary antibody + blocking solution from each well
and washed the wells three times (3x) with PBS (room temperature); in between each wash, the
wells were incubated at room temperature for 15 minutes with PBS.
This was performed in the dark*:
Then we added 1mL of secondary antibody + blocking solution into each well. Following
this, we wrapped each well in aluminum foil and incubated them at room temperature for 2 hours
in the dark.* The primary purpose of performed said steps (i.e incubation with 2º antibody and
preparation of the 2º antibody) in the dark is to prevent light from reacting with the secondary
antibody, a property we will exploit when using the Keyence, an all-in-one fluorescence
microscope (Keyence Corporation of America, Itasca, IL, USA). After 2 hours of incubation at
room temperature, we washed each well by vacuum aspirating the secondary antibody and adding
PBS to each well three times; again, between each wash we incubated the well plates for 15
minutes. We wrapped each well plate in parafilm and aluminum foil and placed them in the
refrigerator.
Part 6 of dorsal root ganglion (DRG) harvest: imaging for data analysis
Once all the cells were staining with ßIII tubulin, we imaged them using the BZ-X810
all-in-one fluorescence microscope, or the Keyence (Keyence Corporation of America, Itasca, IL,
USA). To limit user bias, we decided the visualize neurons in the outer edges of each well plate.
Specifically, we looked at the same general area of each well (i.e upper right quadrant of the well/
coverslip) to ensure consistency without bias.
When we imaged the cells that were incubated for only 24 hours and subsequently
stained, we observed that there were no neurite outgrowths and decided not to quantify these
images/neurons. We imaged the cells that underwent a media exchange and were incubated for
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seven days before being fixed. Once the images were taken, the image files were renamed as
letter codes (i.e A, B, C, etc) as to blind the investigator quantifying them. In total, three
investigators quantified the neurite outgrowths using NeuronJ (a plug in for the software ImageJ)
and all were blinded. Once all quantifications were performed, everyone was unblinded. We
utilized the software PRISM to analyze the data following each blinded quantification. For this
experiment, we utilized the ANOVA test to determine whether the results obtained were
statistically significant (denoted by a p-value of 0.05 or less) as there were at least three
independent variables (IH, SH, normoxia). In addition, we decided to utilize Sholl analysis to
further quantify neurite outgrowth as a way to provide another tool that can be used to quantify
neurite outgrowth in a more efficient way. Moreover, Sholl analysis is a more accurate way to
quantify dendritic arbors7 and as such, we decided to utilize this technique to compare to our
manual traces of neurite outgrowth using ImageJ.
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Intermittent hypoxia: note that well 12 has
only 1mL of NBA media due to inadequate
solution; likely an error in calculation

Normoxia: note that the stars represent lack
of cells/media in wells 6 and 12; well 11 only
has 1mL of NBA media - again, likely error
in calculations

Sustained hypoxia: note that well 12
has only 1mL of NBA media; likely
error in calculation

Figure 3: schematic image of well plates
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Figure 4: Concentric circles used to measure
dendritic arbors from the center (i.e soma) to
periphery

Figure 5: Graph depicting Sholl analysis - as the
distance from the soma increases, the number of
crossing/intersections increase then decreases7
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CHAPTER 3: RESULTS
Neurite outgrowth analysis using NeuronJ

The results we obtained for this experimental paradigm did not support the hypothesis.
Previously, we hypothesized that sustained hypoxia treatment would result in the greatest neurite
outgrowth followed by intermittent hypoxia; normoxia would result in the least amount of
outgrowth. Following five days of specific treatment paradigms established previously, rats
treated in-vivo with sustained hypoxia at moderate oxygen levels (i.e 10%) showed the most
resistance to neurite outgrowth. It is important to note here that the results obtained were not
statistically significant (p-value = 0.1626). Indeed, the average neurite outgrowth taken across all
three quantifiers (see tables 1-3) reveals that normoxia had the greatest total neurite outgrowth
when compared to sustained hypoxia and intermittent hypoxia.
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Table 1: Each image letter represents an image of a neuron taken with Keyence. The total
neurite outgrowth is the total taken across all three quantifiers. The average length is shown in
inches for sustained hypoxia treatment

Total neurite outgrowth (inches)
Images

Sustained hypoxia (n=12)

U

41.57266667

V

23.60483333

W

23.43466667

X

31.94133333

Y

20.34183333

Z

28.787

AA

15.69666667

BB

6.723333333

CC

8.847666667

DD

2.768666667

EE

11.60733333

FF

8.231333333

Average

18.62977778
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Table 2: Each image letter represents an image of a neuron taken with Keyence. The total
neurite outgrowth is the total taken across all three quantifiers. The average length is shown in
inches for intermittent hypoxia treatment

Total neurite outgrowth (inches)
Images

Intermittent hypoxia (n=11)

A

9.598

B

71.88266667

C

12.654

D

23.95266667

E

13.44633333

F

29.624

G

24.11933333

H

15.71566667

I

29.32666667

J

40.04066667

K

11.43066667

Average

25.61733333
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Table 3: Each image letter represents an image of a neuron taken with Keyence. The total
neurite outgrowth is the total taken across all three quantifiers. The average length is shown in
inches for normoxia treatment

Total neurite outgrowth (inches)
Image

Normoxia (n=9)

L

14.32283333

M

72.09733333

N

6.832

O

65.96466667

P

10.51133333

Q

20.39733333

R

41.4655

S

33.715

T

41.49633333

Average

34.08914815
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Table 4: One way ANOVA test; p-value: 0.1626,
not statistically significant
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C

D
Legend
Sustained Hypoxia
Intermittent Hypoxia
Normoxia

Total Neurite Length (pixels)

Total in vitro DRG neurite outgrowth
from subjects treated with in vivo
SH, IH, and Normoxia
10000
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4000
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E

Figure 6: (A) This graph shows dorsal root ganglion outgrowth for each treatment paradigm;
sustained hypoxia (n=12) is on the left, intermittent hypoxia (n=11) is in the middle and
normoxia (n=9) is on the right. (B) This image, used with permission by ALS, shows the
automated neurite outgrowth following the Sholl analysis. As such, it is shows a similar trend to
the manual traces shown in (A). (C) This is an image obtained by fluorescent microscopy of a
single DRG showing a neurite outgrowth projecting from its soma. (D) This image, used with
permission by ALS, shows the Sholl analysis which trends towards increasing neurite
outgrowth. It is evident that IH treatment and normoxia has more neurite outgrowths as
compared to SH but it can also be extrapolated that SH treatment allowed for more sustained
outgrowth i.e there are more crossings as distance increased. (E) This graph depicts the results
following independent quantifications by all three quantifiers (ALS, JHY, CED).
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CHAPTER 4: DISCUSSION

There is considerable research that describes the effects of intermittent and sustained
hypoxia on neural plasticity following cervical spinal cord injuries (SCI). In particular, a study
conducted by Silverstein and Alilain (2021) sought to exploit the difference between fixed
duration intermittent hypoxia (12 cycles of 5 minutes of hypoxia interspersed with normoxia for
2hrs and 32min) and varied duration intermittent hypoxia (condition where the hypoxic episode
varied from either 2 minutes or 8 minutes) 1 week and 8 weeks post C2Hx. Moreover, this study
looked to explore a novel pattern sensitivity in order to determine the best treatment paradigm to
generate phrenic long term facilitation (pLTF) in rats as a means to hopefully translate this
treatment method to the clinic. Further, this highlights a point mentioned previously regarding
LTF. Following a cervical SCI, there are usually spared or latent pathways that can innervate the
phrenic motor nucleus. As such, research has been done to potentially exploit this pathway and
restore respiratory motor function following injury. One of the mechanism that leads to LTF is the
serotonergic pathway, termed the Q pathway, as intermittent hypoxia has been shown to increase
serotonergic signaling, and thus LTF1. Yet this is determined by the availability of serotonin.
Research has shown that following a hemisection, serotonin and serotonergic sprouting is most
abundant 8 weeks post injury. From this study, it was determined that FD-IH led to greater
respiratory motor recovery when compared to VD-IH 8 weeks post injury.1
Indeed, while a lot of research has been performed on the effects of IH and SH in relation
to LTF, there haven’t been many studies that looked at neurite outgrowth and regeneration. As
such, we decided to utilize DRGs as a means to determine their regenerative capabilities. Inspired
by an experiment performed by Hutson et al (2019) and Cho et al (2015), our experimental design
focused on exposing rats to an enriching environment i.e intermittent and sustained hypoxia and
normoxia in order to determine whether these conditions would upregulate certain transcription
factors and proteins (i.e HIF1a, VEGFA) in-vivo and how these effects would translate once
neurons (DRGs) were harvested and plated. Moreover, the idea was to determine if the treatment
paradigms performed in-vivo would translate once cells (DRGs) were ex-plant onto well plates.
The experiments carried out by Cho et al (2015) revealed that acute intermittent hypoxia not only
upregulated HIF1a in DRGs following injury, but also activated downstream protein VEGFA as a
means to further stimulate axonal regeneration on DRGs. The findings from this experiment show
that rats exposed to normoxia showed the greatest response and thus resulted in the greatest total
neurite outgrowth. This result contradicts our hypothesis that sustained hypoxia would have the
greatest neurite outgrowth. Moreover, this shows that there were other factors that led to
normoxia having the greatest neurite outgrowth. These results do not point to the idea that
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hypoxia treatment does not lead to neurite outgrowth. Indeed, from the experimental data, it can
be seen that both intermittent and sustained hypoxia treatments result in outgrowth. As such, our
results contribute to other studies showing neurite outgrowth in response to hypoxic treatment
paradigms.
HIF1a is induced during exposure to hypoxia and VEGFA is an injury induced HIF1a
target gene6. The Cho et al (2015) experiment, performed in mice, revealed two important facets.
Firstly, during an in-vitro experiment using DRGs, continuous (i.e sustained) hypoxia treatment
led to the upregulation of HIF1a (1.5 fold increase) in addition to an increase in phosphorylation
of protein kinase C (PKC), a key protein usually found downstream of the Gq pathway (i.e
adenosine A2).6 Specifically, treatment was applied immediately after injury, and it was shown
that delayed treatment (i.e 4, 8, 12h post injury) does not result in regeneration. Secondly, acute
intermittent hypoxia at 8% oxygen level, which constitutes a severe hypoxic condition, in in-vivo
injured mice resulted in an upregulation of HIF1a and its downstream target, VEGFA. Further,
this treatment paradigm resulted in axonal regeneration when compared to normoxia. Similar to
the experiment carried out by Cho et al (2015), Silverstein (2020) sought to investigate the effects
intermittent/sustained hypoxia and normoxia treatment paradigms in uninjured adult rats had in
HIF1a/VEGF expression. Upon treating uninjured rats (n=9 with 3 cohorts per treatment
paradigm), CNS tissue from the brain, brainstem, cerebellum and spinal cord were harvested to
measure HIF1a and VEGF. Interestingly, it was revealed that the normoxia condition resulted in
the greatest expression of HIF1a while moderate sustained hypoxia resulted in the greatest
expression of VEGF. Specifically, HIF1a was found to be at the highest level in the spinal cord
following intermittent hypoxia which could point to the idea that intermittent hypoxia and HIF1a
could be directly involved in improving respiratory motor function. Furthermore, these results
corresponds well with my results in that moderate intermittent hypoxia indeed led to neurite
outgrowth. Future directions would then include analyzing the collected media for VEGFA/HIF1a
levels, as well as staining for HIF1a/VEGFA, and comparing the results to each treatment
paradigm’s total neurite outgrowth. It would also be interesting introduce severe intermittent/
sustained hypoxia and their effects on both neurite outgrowth and HIF1a/VEGFA profile in rats. It
is important to include different measures of hypoxic exposure as this would give us a better
understanding as it relates to giving the proper dose in clinical trials, and beyond. As we know,
expression of a protein is not a consequence of one set of actions. As such, it would be interesting
to further experiment with other transcription factors such as JUNB, VEGFB, ENO2, etc6 to
determine which factors are upregulated or downregulated, either separately or together, to
promote axonal regeneration.
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It is important here to address some variables that could have led to our results. For
example, upon repeating this experiment, it would be beneficial to decrease the volume of cells
being culture. Moreover, for this experiment, we cultures on average 5,000 cells per well plate
and this could have led to “overcrowding” of the well plate. This is important as it relates to the
manner in which some neurite outgrowths appeared. As seen in figure 8, it is evident that while
there were neurite outgrowth projecting from the soma, some of these projections also appear to
project back to the soma albeit at a different point. Moreover, we predict that while neurons assist
surround cells to project processes outward, it is also very possible that these same neurons also
inhibit the outgrowth of other neurons by releasing inhibitory chemicals. Indeed, previous studies
working with rat hippocampal tissue revealed that it is neither chemicals nor fibroblasts that
provide inhibition to growth. Rather, it appears that it is an innate feature of the scarred surface
that, in the absence of oligodendrocytes, resulted in the failure of neurite outgrowth.8,9 As such,
this points to the notion that further research needs to be performed with a lower density cell
culture with the addition of conditioned media that could allow for neurite outgrowth. Moreover,
the conditioned media here would serve as “neurons” that would help facilitate each other’s
outgrowth. In addition, it would also bear fruitful to repeat this research paradigm using same
density of cells and possibly using a larger well plate, again with conditioned media, to allow for
more room for neurite outgrowth.
As we know, neurons send information down the axon to the axon terminal where it will
synapse with a dendrite process of another neuron. Thus, it is important for the proper functioning
of not only the central nervous system but with the body as a whole. Because of this, it is
important to have a way to quantify dendritic arborization in relation to either injury or disease, as
changes to dendrites can result in decreased neuronal communication and function.10 Moreover, it
is essential to understand the dendritic arbors and their complexities in order to determine
whether we are heading in the right direction. If dendritic processes are critical for the CNS/PNS
to properly function, it is important to quantify and study these arborizations as it may give us
valuable insight into role of dendritic processes in cervical SCI. Indeed, one of the earlier studies
observing dendritic regeneration by Ramon y Cajal in 1928 showed that there were no dendritic
regrowth following injury to pyramidal neurons found in the cerebral cortex but contusion in the
spinal cord resulted in dendritic regrowth.12 Juxtaposing this study, Thompson-Peer et al (2016)
looked at dendritic regrowth in Drosophila larvae and indeed confirmed that PNS neurons have a
more robust mechanism in which to regenerate as opposed to CNS neurons. Despite the fact that
dendritic regeneration in response to injury had a different morphology as compared to uninjured
controls, it still validates the claim that PNS neurons have an elusive regenerative property not
found in the CNS. As such, whether it is a cell intrinsic pathway or environmental enrichment that
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allows for regeneration, regardless of CNS/PNS neurons warrants further investigation. Thus, in
addition to manual traces, we used the Sholl analysis, which measures the neurite outgrowth as it
crosses each concentric circle. When we look at in-vivo experiments that look to measure
dendritic regeneration following injury, it is easy to determine that the outgrowth is indeed a
dendritic process. Moreover, when we compare that to our experiment here, which observed invitro outgrowth, it is difficult to say for certain whether the outgrowth is dendritic or axonal in
nature. As such, we can simply refer to it as neurite outgrowth. This analysis would be able to
give us a better idea of neurite arborization and its complexity, or the measure at which neurons
can interact with other neurons. As such, it provides useful information such as the number of
branches each neurite outgrowths could have possibly had, something that cannot be traced
manually using NeuronJ. Indeed, based on figure 6D, it is evident that SH leads to a reduced
number of neurite outgrowth. If we look at neurite outgrowth following IH treatment and
normoxia, there is more neurite outgrowth extending from the soma albeit it is not sustained. We
can compare the neurite outgrowth trends for SH and IH and as described previously, while IH
and SH do promote neurite, it appears that SH trends towards a more sustained neurite outgrowth
pattern. Experiments from in-vitro DRG cultures (figure 9D) show the same trend for its Sholl
analysis in the sense that SH lead to more neurite outgrowth but also for a sustained period of
time. Further research needs to be performed to determine why SH lead to juxtaposing neurite
outgrowth but an overall trend that seemingly leads to a a more sustained neurite outgrowth.
Additionally, it would be worth performing ELISA of media collected following incubation of
cell cultures for 7 days (see methods) to measure HIF1a and VEGFA levels for each treatment
paradigm. Moreover, we decided to utilize this experiment as the pilot project in which to test a
new MATLAB code that will help us further and, more readily and accurately, quantify neurite
arborization in hope of better understanding manner in which regeneration appears, but
importantly where the neurite outgrowth is spatially in relation to the soma.
Additionally, because the premise of our experiment looked at three separate independent
variables as it would relate to one specific dependent variable, neurite outgrowth, we decided to
utilize the ANOVA analysis to analyze statistical significance. Research discussed by Wilson et al
(2017)13 simple, linear model such as the ANOVA does not provide an accurate analysis of results
during intra-class correlations, specifically resulting in an inaccurate p value. Moreover, this
experiment can be considered an intra-class correlation in the sense that we analyzed sampled
multiple neurons from a single animal per treatment paradigm. As such, Wilson et al (2017)13
showed that a mixed effect model analysis would better account for intra-class correlations and
allow for a more accurate standard deviation and thus more accurate p values. In future studies, it
would be beneficial to utilize a more accurate system such as the mixed effect models of analysis
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for the Sholl analysis and the measurement of total neurite outgrowth, in order to more accurately
measure p value.
In a juxtaposing study by Caroline Devine (figure 9A-D), dorsal root ganglion (DRGs)
were subject to moderate sustained hypoxia (10% oxygen level; ProOx C21 and incubator subchamber (Biospherix, Ltd, New York, USA)) in-vitro for five consecutive days, for 2 hours and
32 minutes, alongside a normoxia condition (20% oxygen level). It is important to note here that
this particular study did not treat a cohort of DRGs with intermittent hypoxia due to limitations
presented by the incubator. The results from that study reveal that the greatest neurite outgrowth
resulted in response to sustained hypoxia (mean growth 89.52 inches) when compared to
normoxia (mean growth 52.64 inches), contrasting the results from our experiments (figure 6AE). Moreover, these results were of statistical significance which allows us to ascertain that the
results are due to a specific cause and not by chance. Of significance is the Devinney et al (2016)
experiment performed that revealed the opposite response to moderate sustained hypoxia. It was
shown that moderate intermittent and moderate sustained hypoxia treatment paradigms does not
result in phrenic motor facilitation (pMF) nor pLTF due to inhibitory cross-talk between the
serotonergic/adenosine pathways.14 Moreover, it was revealed by Devinney et al (2016) that
pharmacologically inhibiting spinal adenosine A2 receptors resulted in pMF after treatment with
moderate sustained hypoxia. Additionally, it was also shown that severe acute sustained hypoxia
triggered pMF in an adenosine A2 dependent manner while simultaneously inhibiting serotonin
receptors. As such, further study has to be performed in order to determine the reason why neurite
outgrowth was the greatest following moderate sustained hypoxia in this experiment, whether it is
due to another underlying mechanism or one that inhibited either adenosine A2 receptors or
serotonin receptors.14 Furthermore, one of the possible errors described by Caroline Devine is that
some of the well plates dried out. As such, this possible error needs to be exploited further as it
could explain a greater neurite outgrowth due to less inhibitory factors that could arise from less
cell volume in the well plates. In addition, it could bear fruitful to investigate the possible effects
of neurite outgrowth with and without conditioned media. Moreover, if sustained hypoxia
treatment promoted the greatest neurite outgrowth in less media and possibly less cell volume, it
is worth investigating whether conditioned media would bolster the effects of neurite outgrowth
and vice versa.
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Figure 7: This graph, used with permission from ALS, shows the expression
of HIF1a across the different treatment paradigms. As you can see, the
highest expression of HIF1a occurs in normoxia but within the scope of
intermittent hypoxia, HIF1a expression is highest in the spinal cord. This
allows us to speculate the effects of HIF1a in respiratory plasticity.

Figure 8: image of stained DRG showing
neurite projections leaving soma but
warping back to soma at a different point
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Figure 9: (A) This graph, used with permission by CED, depicts statistically significant results showing SH had
a profound effect in neurite outgrowth as compared to normoxia. (B) This graph, used with permission by CED
depicts the results following independent quantifications by all three quantifiers (ALS, JHY, CED) (C) This
chart, used with permission by Caroline Devine, depicts the unpaired t-test showing statistically signifiant
results pointing at the idea that neurite outgrowth following in-vitro sustained hypoxia treatment is attributable
to a cause. (D) This Sholl analysis, used with permission by AS and CED, shows increasing neurite outgrowth
as you move away from the soma indicating possible branching patterns in outgrowth. It is evident that SH
treatment leads to more sustained outgrowth as compared to normoxia and thus more crossings.
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CHAPTER 5: CONCLUSION
This experiment sought to investigate the effects of enriched treatment environments such
as intermittent hypoxia, sustained hypoxia and normoxia on neurite outgrowth patterns.
Importantly, this study can be considered a hybrid of both in-vivo and in-vitro experiments. In that
sense, we were interested in investigating how well treatment paradigms would translate once
cells in rats treated in-vivo, have been ex-planted and cultured in well plates. This experiment
contributes to other experiments that seek to exploit moderate intermittent and sustained hypoxia
treatment paradigms as a way to promote axonal regeneration in injury and disease processes.
Impairment of breathing function following cervical spinal cord injury is devastating and can
ultimately lead to death. As such, this experiment shows that intermittent hypoxia indeed facilities
neurite outgrowth and it is our hope this will contribute to other experimental models that can
contribute to benefit the quality of life of individuals with not only spinal cord injuries but other
devastating neurological disorders.
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